VASP and chronic myelogenous leukemia, BCR-ABL1 positive: However, a recent publication showed imatinib-induced vasodilator-stimulated phosphoprotein (VASP) phosphorylation on S157 in K562 cells and in CML patients’ bone marrow cells after imatinib treatment [51].